Latest Safety News

Group 6 Metals has secured a pivotal underground mining contract with HMR Drilling Services, marking a decisive step toward sustained production at the Dolphin Tungsten Project on King Island.

Noxopharm reports preclinical data revealing SOF-SKN’s active ingredient remains in skin tissues for about 3.5 days with minimal systemic absorption, supporting less frequent dosing and sustained activity for cutaneous lupus treatment.

Paladin Energy has increased its FY2026 uranium production guidance at the Langer Heinrich Mine to 4.5-4.8 million pounds, driven by strong operational performance. Concurrently, the company secured environmental approval for its Patterson Lake South project in Canada, although a legal challenge looms.

AdNeo Limited has locked in a five-year contract worth approximately $246,400 to deliver and host a custom-branded learning platform for Amplitude Energy, reinforcing its foothold in Australia's energy sector.

Northern Star Resources strengthened its cash flow and maintained FY26 production guidance above 1.5 million ounces despite cost inflation and operational challenges. The KCGM Mill Expansion remains on track for early FY27 commissioning, underpinning confidence reflected in a $500 million share buy-back announcement.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

South32's March quarter saw a tragic fatality at Worsley Alumina and weather disruptions, yet the miner delivered solid operational results and progressed its Hermosa zinc-lead-silver project. Production guidance was mostly maintained, with a notable revision lower for Australia Manganese due to water management issues.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.

Red Sky Energy is raising approximately AUD 4.2 million through a fully underwritten non-renounceable rights issue priced at 0.1 cents per share. The capital will fund participation in Santos-operated wells and support ongoing operations.

Invion Limited is broadening its non-melanoma skin cancer trial to include basal cell carcinoma patients following encouraging safety and efficacy data from squamous cell carcinoma cohorts, targeting the largest skin cancer segment.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.

dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.